Evidence map›Paper›PMID 37019153›Full record

ArticleEmerging infectious diseases2023

Emerging Invasive Group A Streptococcus M1

Xiangyun Zhi, Ho Kwong Li, Hanqi Li, Zuzanna Loboda, Samson Charles, Ana Vieira, Kristin Huse, Elita Jauneikaite, Lucy Reeves, Kai Yi Mok and 3 more

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Predominance of M1European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Article
  3. Whole Genome Sequencing Analysis of Group AJournal of Korean medical science · 2026
    Article
  4. Mortality Among Patients With Invasive Group A Streptococcal Infections Caused by the M1UK Lineage: A Retrospective Cohort Study in England and Wales.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  5. Article
  6. Article
  7. Severe invasiveJournal of intensive medicine · 2025
    Article
  8. Article
  9. Review
  10. Additional biomarkers and emm types associated with group A streptococcal toxic shock syndrome: a Japanese nationwide observational study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Observational
  11. Article
  12. Article
  13. Article
  14. Trends in the growing impact of group A Streptococcus infection on public health after COVID-19 pandemic: a multicentral observational study in Okayama, Japan.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Observational
  15. Characterization ofMicroorganisms · 2025
    Article
  16. Review
  17. Article
  18. Invasive group A Streptococcus infection (Streptococcus pyogenes): Current situation in Spain.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Xiangyun Zhi
Ho Kwong Li
Hanqi Li
Zuzanna Loboda
Samson Charles
Ana Vieira
Kristin Huse
Elita Jauneikaite
Lucy Reeves
Kai Yi Mok
Juliana Coelho
Theresa Lamagni
Shiranee Sriskandan

Funding

Medical Research Council MR/P022669/1
6 · The paper itself

Abstract

Increasing reports of invasive Streptococcus pyogenes infections mandate surveillance for toxigenic lineage M1

Indexed as

Scarlet FeverStreptococcal InfectionsAllelesAntigens, BacterialBacterial Outer Membrane ProteinsEnglandHumansPolymerase Chain ReactionStreptococcus pyogenesAntigens, BacterialBacterial Outer Membrane Proteinsallele-specificbacteriaemerging lineageemm1Englandgroup A StreptococcusiGASM1UKmolecular diagnosticsPCRrespiratory infectionsscarlet feverstreptococciStreptococcus pyogenessuperantigen

Identifiers

PMID37019153
PMCPMC10124639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.